Jump to ContentJump to Main Navigation
Show Summary Details

Acta Pharmaceutica

The Journal of Croatian Pharmaceutical Society

4 Issues per year


IMPACT FACTOR increased in 2015: 1.212
5-year IMPACT FACTOR: 1.620

SCImago Journal Rank (SJR) 2014: 0.353
Source Normalized Impact per Paper (SNIP) 2014: 0.743
Impact per Publication (IPP) 2014: 1.275

Open Access
Online
ISSN
1846-9558
See all formats and pricing



Select Volume and Issue

Issues

Synthesis of certain pyrrole derivatives as antimicro-bial agents

Mosaad Mohamed
  • Organic Chemistry Department Faculty of Pharmacy, Helwan University, Cairo, Egypt
/ Ramdan El-Domany
  • Microbiology and Immunology Department, Faculty of Pharmacy, Helwan University, Cairo, Egypt
/ Rania Abd El-Hameed
  • Organic Chemistry Department Faculty of Pharmacy, Helwan University, Cairo, Egypt
Published Online: 2009-06-29 | DOI: https://doi.org/10.2478/v10007-009-0016-9

Synthesis of certain pyrrole derivatives as antimicro-bial agents

In an effort to establish new pyrroles and pyrrolo[2,3-d] pyrimidines with improved antimicrobial activity we report here the synthesis and in vitro microbiological evaluation of a series of pyrrole derivatives. A series of new 2-aminopyrrole-3-carbonitriles (1a-d) were synthesized from the reaction of benzoin, primary aromatic amines and malononitrile, from which a number of pyrrole derivatives (2a-d to 5a-d) and pyrrolo[2,3-d]pyrimidines (6a-d to 10a, d) were synthesized. The in vitro antimicrobial testing of the synthesized compounds was carried out against Gram-positive, Gram-negative bacteria and fungi. Some of the prepared compounds, [2-amino-1-(2-methylphenyl)-4,5-diphenyl-1H-pyrrole-3-carbonitriles (1b), 2-amino-3-carbamoyl-1-(3-methylphenyl)-4,5-diphenyl-1H-pyrroles (2b), N-(3-cyano-1-(2-methylphenyl)-4,5-diphenyl-1H-pyrrol-2-yl)-acetamides (3b), N-(3-cyano-1-(3-methylphenyl)-4,5-diphenyl-1H-pyrrol-2-yl)-acetamides (3c), 2-amino-1-(4-methoxyphenyl)-4,5-diphenyl-3-tetrazolo-1H-pyrroles (5d), 7-(4-methoxyphenyl)-5,6-diphenyl-7H-pyrrolo [2,3-d]pyrimidin-4(3H)-ones (7d), 7-(3-methylphenyl)-5,6-diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4(3H)-thione (9b) and N-(7-(2-methylphenyl)-5,6-diphenyl-7H-pyrrolo[2,3-d] pyrimidine)-N-aryl amines (10a)] showed potent antimicrobial activity.

Sinteza derivata pirola kao antimikrobnih tvari

U radu je opisana sinteza novih derivata pirola i pirolo[2,3-d]pirimidina s poboljšanim antimikrobnim djelovanjem. Reakcijom benzoina, primarnih aromatskih amina i malononitrila sintetizirana je serija novih 2-aminopirol-3-karbonitrila (1a-d), iz kojih su potom pripravljeni derivati pirola (2a-d do 5a-d) i pirolo[2,3-d]pirimidina (6a-d do 10a, d). Sintetiziranim spojevima ispitano je in vitro antimikrobno djelovanje na različite Gram-pozitivne, Gram-negativne bakterije i gljivice. Neki od sintetiziranih spojeva [2-amino-1-(2-metilfenil)-4,5-difenil-1H-pirol-3-karbonitril (1b), 2-amino-3-karbamoil-1-(3-metilfenil)-4,5-difenil-1H-pirol (2b), N-(3-cijano-1-(2-metilfenil)-4,5-difenil-1H-pirol-2-il)-acetamid (3b), N-(3-cijano-1-(3-metilfenil)-4,5-difenil-1H-pirol-2-il)-acetamid (3c), 2-amino-1-(4-metoksifenil)-4,5-difenil-3-tetrazolo-1H-pirol (5d), 7-(4-metoksifenil)-5,6-difenil-7H-pirolo[2,3-d]pirimidin-4(3H)-on (7d), 7(3-metilfenil)-5,6-difenil-7H-pirolo[2,3-d]pirimidin-4(3H)-tion (9b) i N-(7-(2-metilfenil)-5,6-difenil-7H-pirolo[2,3-d]pirimidin)-N-aril amin (10a)] imaju snažno antimikrobno djelovanje.

Keywords: pyrrole; pyrrolopyrimidine; antimicrobial activity

Keywords: pirol; pirolopirimidin; antimikrobno djelovanje

  • S. Petruso, S. Bonanno, S. Caronna, M. Ciofalo, B. Maggio and D. Schillaci, A new synthesis of bioactive analogs of monodeoxypyoluteorin, J. Heterocyclic Chem. 31 (1994) 941--945. [Crossref]

  • M. V. Raimondi, S. Cascioferro, D. Schillaci and S. Petruso, Synthesis and antimicrobial activity of new bromine-rich pyrrole derivatives related to monodeoxypyoluteorin, Eur. J. Med. Chem. 41 (2006) 1439--1445; DOI 10.1016/j.ejmech.2006.0.009. [Crossref]

  • D. Schillaci, S. Petruso and V. Sciortino, 3,4,5,3,5-Pentabromo-2-(2-hydroxybenzoyl)pyrrole: a potential lead compound as anti-Gram-positive and anti-biofilm agent, Int. J. Antimicrob. Ag. 25 (2005) 338--340; DOI: 10.1016/j.ijantimicag.2004.11.014. [Crossref]

  • M. Biava, R. Fioravanti, G. C. Porretta, D. Deidda, C. Maullu and R. Pompei, New pyrrole derivatives as antimycobacterial agents analogs of BM 212, Bioorg. Med. Chem. Lett. 9 (1999) 2983--2988; DOI: 10.1016/s0960-894x(99)00510-7. [Crossref]

  • M. Biava, G. C. Porretta, D. Deidda, R. Pompei, A. Tafi and F. Manetti, Importance of the thiomorpholine introduction in new pyrrole derivatives as antimycobacterial agents analogues of BM 212, Bioorg. Med. Chem. 11 (2003) 515--520; DOI: 10.1016/s0968-0896(02)00455-8. [Crossref]

  • G. H. Jana, S. Jain, S. K. Arora and N. Sinha, Synthesis of some diguanidino 1-methyl-2,5-diaryl-1H-pyrroles as antifungal agents, Bioorg. Med. Chem. Lett. 15 (2005) 3592--3595; DOI: 10.1016/j.bmcl.2005.05.080. [Crossref]

  • Y. Misumo, M. J. Ikehara, K. A. Watanabe, S. Suzuki and T. Itoh, Synthetic studies of potential antimetabolites. IX. The anomeric configuration of tubercidin, J. Org. Chem. 28 (1969) 3329--3331.

  • Q. Dang and J. E. Gomez-Galeno, An efficient synthesis of pyrrolo[2,3-d]pyrimidines via inverse electron demand Diels-Alder reactions of 2-amino-4-cyanopyrroles with 1,3,5-triazines, J. Org. Chem. 67 (2002) 8703--8705; DOI: 10.1021/jo026309d. [Crossref]

  • K. V. Rao, Structure of sangivamycin, J. Med. Chem. 11 (1968) 939--941; DOI: 10.1021/jm00311a005. [Crossref]

  • A. Gangjee, X. Lin and S. F. Queener, Design, synthesis, and biological evaluation of 2,4-diamino-5-methyl-6-substituted-pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors, J. Med. Chem. 47 (2004) 3689--3692; DOI: 10.1021/jm0306327. [Crossref]

  • P. M. Traxler, P. Furet, H. Mett, E. Buchdunger, T. Meyer and N. Lydon, 4-(Phenylamino)pyrrolopyrimidines: Potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase, J. Med. Chem. 39 (1996) 2285--2290; DOI: 10.1021/jm960118j. [Crossref]

  • M. S. Mohamed, A. E. Rashad, M. E. A. Zaki and S. S. Fatahala, Synthesis and antimicrobial screening of some fused heterocyclic pyrroles, Acta Pharm. 55 (2005) 237--249. [PubMed]

  • H. J. Roth und K. Eger, Synthese von 2-Amino-3-cyano-pyrrolen, Arch. Pharm. 18 (1974) 179--185.

  • H. J. Roth und K. Eger, Synthese von pyrrolo[2,3-d]pyrimidinen, Arch. Pharm. 18 (1974) 252--258.

  • A. C. Gales, H. S. Sader and R. N. Jones, Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program, Diagn. Mic. Infec. Dis. 44 (1997--2000) 289--294.

  • A. Jorgensen, K. A. M. El-Bayouki and E. B. Pedersen, Phosphorus pentoxide in organic synthesis. XX: Synthesis of N-aryl-7H-pyrrolo[2,3-d]pyrimidin-4-amines, J. Heterocyclic Chem. 22 (1985) 859--863. [Crossref]

  • C. G. Dave and M. C. Shukla, Diethyl ethoxymethylenemalonate in triheterocycles: a new synthesis of pyrido[3,2-e]pyrimido[1,2-c]pyrimidines, J. Heterocyclic Chem. 34 (1997) 1805--1808. [Crossref]

  • C. G. Dave and R. D. Shah, Synthesis of 7H-tetrazolo[1,5-c]pyrrolo[3,2-e]pyrimidines and their reductive ring cleavage to 4-aminopyrrolo[2,3-d]pyrimidines, J. Heterocyclic Chem. 35 (1998) 1295--1300. [Crossref]

  • C. G. Dave, Synthesis and reactions of fluoroaryl substituted 2-amino-3-cyanopyrroles and pyrrolo[2,3-d]pyrimidines, J. Heterocyclic Chem. 36 (1999) 729--733. [Crossref]

  • G. F. Gad, R. A. El-Domany and H. M. Ashour, Antimicrobial susceptibility profile of Pseudomonas aeruginosa isolates in Egypt, J. Urol. 180 (2008) 176--181; DOI: 10.1016/j.juro.2008.03.081. [Crossref]


Published Online: 2009-06-29

Published in Print: 2009-06-01


Citation Information: Acta Pharmaceutica. Volume 59, Issue 2, Pages 145–158, ISSN (Online) 1846-9558, ISSN (Print) 1330-0075, DOI: https://doi.org/10.2478/v10007-009-0016-9, June 2009

This content is open access.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Radhakrishnamraju Ruddarraju, Adharvana Chari Murugulla, Shobha Donthabakthuni, Ravindar Kotla, Sandeep Deshmukh, Ravichandar Maroju, and Sadhanandam Palle
Journal of Heterocyclic Chemistry, 2016, Page n/a
[2]
Laurens M. De Coen, Thomas S. A. Heugebaert, Daniel García, and Christian V. Stevens
Chemical Reviews, 2015
[3]
[4]
Alhussein A. Ibrahim, Mohamed F. El-Shehry, Hanaa M. Hosni, Abd El-Galil E. Amr, and Mohamed M. Abdalla
International Journal of Pharmacology, 2015, Volume 11, Number 7, Page 806
[5]
Vanessa Prieur, M. Dolors Pujol, and Gérald Guillaumet
European Journal of Organic Chemistry, 2015, Page n/a
[6]
Dima A. Sabbah, Musaab Saada, Reema Abu Khalaf, Sanaa Bardaweel, Kamal Sweidan, Tariq Al-Qirim, Amani Al-Zughier, Heba Abdel Halim, and Ghassan Abu Sheikha
Bioorganic & Medicinal Chemistry Letters, 2015
[7]
Namratha Bhandari and Santosh L. Gaonkar
Chemistry of Heterocyclic Compounds, 2015, Volume 51, Number 4, Page 320
[8]
Mosaad S. Mohamed, Rania H. Abd El-Hameed, Amira I. Sayed, and Sameh H. Soror
Archiv der Pharmazie, 2015, Volume 348, Number 3, Page 194
[9]
Jelena Dodonova and Sigitas Tumkevicius
RSC Advances, 2014, Volume 4, Number 68, Page 35966
[10]
Eman M. Flefel, Waled A. Tantawy, Randa E. Abdel-Mageid, Abd El-Galil E. Amr, and Rolla Nadeem
Research on Chemical Intermediates, 2014, Volume 40, Number 4, Page 1365
[11]
M. G. El-Gazzar, N. H. Zaher, and S. Y. El-Tablawy
Medicinal Chemistry Research, 2014, Volume 23, Number 4, Page 1844
[12]
M.S. Mohamed, M.M. Youns, and N.M. Ahmed
European Journal of Medicinal Chemistry, 2013, Volume 69, Page 591
[13]
K. N. Nandeesh, Chandra, M. Mahendra, K. Palani, and K. Mantelingu
Acta Crystallographica Section E Structure Reports Online, 2013, Volume 69, Number 8, Page o1269
[14]
Zohra Bengharez, Zineb El Bahri, and Abderrezzak Mesli
International Journal of Chemical Kinetics, 2013, Volume 45, Number 6, Page 404
[15]
Wanwan Yu, Wenteng Chen, Shen Liu, Jiaan Shao, Zhanying Shao, Haili Lin, and Yongping Yu
Tetrahedron, 2013, Volume 69, Number 7, Page 1953
[16]
Waleed M. Hussein, Samar S. Fatahala, Zainab M. Mohamed, Ross P. McGeary, Gerhard Schenk, David L. Ollis, and Mosaad S. Mohamed
Chemical Biology & Drug Design, 2012, Volume 80, Number 4, Page 500
[17]
Leyla Yurttaş, Yusuf Özkay, Zafer Asim Kaplancıklı, Yağmur Tunalı, and Hülya Karaca
Journal of Enzyme Inhibition and Medicinal Chemistry, 2013, Volume 28, Number 4, Page 830
[18]
V. Prakash, Kamini Kapoor, M. Shet Prakash, Vivek K. Gupta, and Rajni Kant
Acta Crystallographica Section E Structure Reports Online, 2012, Volume 68, Number 5, Page o1521
[19]
Jelena Dodonova, Lina Skardziute, Karolis Kazlauskas, Saulius Jursenas, and Sigitas Tumkevicius
Tetrahedron, 2012, Volume 68, Number 1, Page 329
[20]
Mosaad S. Mohamed, Waleed M. Hussein, Ross P. McGeary, Peter Vella, Gerhard Schenk, and Rania H. Abd El-hameed
European Journal of Medicinal Chemistry, 2011, Volume 46, Number 12, Page 6075
[21]
Khalid Mohammed Hassan Hilmy, Maha M.A. Khalifa, Mohammed Abd Allah Hawata, Reda Mohammed AboAlzeen Keshk, and Abd Almeneam El-Torgman
European Journal of Medicinal Chemistry, 2010, Volume 45, Number 11, Page 5243

Comments (0)

Please log in or register to comment.